Moreover, it these levels were more increased than in other neurodegenerative diseases included in the study, i.e., preclinical AD, MCI due to AD dementia, and FTD, suggesting CSF Ng’s potential role in differential diagnosis of neurodegenerative diseases [29]. This evidence concerns the gene NRGN and frontotemporal dementia.